Literature DB >> 14718088

Hantavirus pulmonary syndrome, southern Chile.

Raúl Riquelme1, Mauricio Riquelme, Antoni Torres, Maria Luisa Rioseco, José Antonio Vergara, Luis Scholz, Andrea Carriel.   

Abstract

We analyzed data from 25 consecutive patients with hantavirus pulmonary syndrome (HPS) admitted to the Puerto Montt and Osorno Regional Hospitals, southern Chile, from 1997 to 2001, emphasizing epidemiologic, clinical, radiographic, treatment, and laboratory aspects. Hemorrhage was frequent (64%), and 48% of patients showed alterations in renal function. Ten patients died (40%). We identified three groups of patients, which included the following: 1) those with the least severe form who had prodromic symptoms without pulmonary involvement; 2) those with moderate illness who had interstitial pulmonary infiltrates, usually needed supplemental nasal oxygen, were hemodynamically stable, and had an APACHE II <12 (none of whom died); and 3) those with the severe form who required mechanical ventilation, frequently had hemodynamic instability (93%), experienced a high mortality rate (77%), and had an APACHE II >12. Mild forms of HPS also exist, which are poorly known; the symptoms could be confounded with those of other viral diseases, leading to underdiagnosis.

Entities:  

Mesh:

Year:  2003        PMID: 14718088     DOI: 10.3201/eid0911.020798

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  8 in total

1.  Andes virus infections in the rodent reservoir and in humans vary across contrasting landscapes in Chile.

Authors:  Fernando Torres-Pérez; R Eduardo Palma; Brian Hjelle; Marcela Ferrés; Joseph A Cook
Journal:  Infect Genet Evol       Date:  2009-07-24       Impact factor: 3.342

2.  Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnostics.

Authors:  Cecilia Vial; Constanza Martinez-Valdebenito; Susana Rios; Jessica Martinez; Pablo A Vial; Marcela Ferres; Juan C Rivera; Ruth Perez; Francisca Valdivieso
Journal:  Diagn Microbiol Infect Dis       Date:  2015-07-29       Impact factor: 2.803

3.  Hantavirus pulmonary syndrome in Argentina, 1995-2008.

Authors:  Valeria P Martinez; Carla M Bellomo; Maria Luisa Cacace; Paola Suarez; Liliana Bogni; Paula J Padula
Journal:  Emerg Infect Dis       Date:  2010-12       Impact factor: 6.883

4.  Hantavirus pulmonary syndrome, Southern Chile, 1995-2012.

Authors:  Raúl Riquelme; María Luisa Rioseco; Lorena Bastidas; Daniela Trincado; Mauricio Riquelme; Hugo Loyola; Francisca Valdivieso
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

5.  Modeling to predict cases of hantavirus pulmonary syndrome in Chile.

Authors:  Elaine O Nsoesie; Sumiko R Mekaru; Naren Ramakrishnan; Madhav V Marathe; John S Brownstein
Journal:  PLoS Negl Trop Dis       Date:  2014-04-24

6.  Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome.

Authors:  René López; Cecilia Vial; Jerónimo Graf; Mario Calvo; Marcela Ferrés; Gregory Mertz; Analía Cuiza; Begonia Agüero; Dante Aguilera; Diego Araya; Ignacia Pailamilla; Flavia Paratori; Víctor Torres-Torres; Pablo A Vial
Journal:  Viruses       Date:  2019-07-30       Impact factor: 5.048

Review 7.  The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome.

Authors:  Christina F Spiropoulou; Anon Srikiatkhachorn
Journal:  Virulence       Date:  2013-07-10       Impact factor: 5.882

Review 8.  Medical treatment of viral pneumonia including SARS in immunocompetent adult.

Authors:  V C C Cheng; B S F Tang; A K L Wu; C M Chu; K Y Yuen
Journal:  J Infect       Date:  2004-11       Impact factor: 6.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.